Entera Bio enterabio.com


Public lists: Pharma Startups (4733)

Entera Bio (NASDAQ: ENTX) is developing novel oral drugs by utilizing its proprietary cutting edge delivery technology This technology protects large molecules and peptides in the GI tract. Oral drug delivery is the most straight forward and user friendly approach to medical treatment. Entera Bio has key personnel with the relevant know how, experience and networks working together to enable rapid development of its products. The company has an experienced management team with more than 50 years...Show all

Entera Bio (NASDAQ: ENTX) is developing novel oral drugs by utilizing its proprietary cutting edge delivery technology This technology protects large molecules and peptides in the GI tract. Oral drug delivery is the most straight forward and user fri...Show all

Company (IPO / Went public)

Phone: 972-54-535-2683

Fax:

Kiryat Hadassah
Minrav Building
Jerusalem, 9112002
Israel

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Entera Bio $20.2M Jun 28, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Entera Bio Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Undisclosed InvestorsOtherUnattributed
PontifaxVenture CapitalHerzliya, IsraelConvertible Note
PontifaxVenture CapitalHerzliya, IsraelConvertible Note
David BondermanAngel Investor (Individual)Texas, United StatesConvertible Note
Arie BelldegrunAngel Investor (Individual)Convertible Note
Joshua KazamAngel Investor (Individual)Convertible Note
See all 5 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Formulations for oral administration of active agents with controlled absorption profile Feb 09, 2016 Application
Treatment of hypoparathyroidism Feb 09, 2016 Application
Formulations for oral administration of active agents Feb 09, 2016 Application
Treatment of bone fractures and defects Feb 09, 2016 Application
Treatment of osteoporosis Feb 09, 2016 Application